scholarly journals Investigation of a neuropsychological screen for chemo-fog

10.4081/35 ◽  
2011 ◽  
Vol 5 (4) ◽  
Author(s):  
Lea Ann Ouimet ◽  
Angela Stewart ◽  
Barbara Collins ◽  
Dwayne Schindler ◽  
Catherine Bielajew
Keyword(s):  
Chemo Fog

Clearing the Air: A Review of Our Current Understanding of “Chemo Fog”

2013 ◽  
Vol 15 (3) ◽  
pp. 260-269 ◽  
Author(s):  
Erin O’Farrell ◽  
Joyce MacKenzie ◽  
Barbara Collins
Keyword(s):  
Current Understanding ◽  
Chemo Fog

scholarly journals Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?

2006 ◽  
Vol 31 (2) ◽  
pp. 129-138 ◽  
Author(s):  
R. B. Raffa ◽  
P. V. Duong ◽  
J. Finney ◽  
D. A. Garber ◽  
L. M. Lam ◽  
...  
Keyword(s):  
Cancer Chemotherapy ◽  
Chemo Brain ◽  
Chemo Fog

scholarly journals Chemo fog becomes clearer

2012 ◽  
Vol 9 (11) ◽  
pp. 609-609
Author(s):  
M. Teresa Villanueva
Keyword(s):  
Chemo Fog

scholarly journals Investigation of a neuropsychological screen for chemo-fog

2011 ◽  
Vol 5 (4) ◽  
pp. 205 ◽  
Author(s):  
Lea Ann Ouimet ◽  
Angela Stewart ◽  
Barbara Collins ◽  
Dwayne Schindler ◽  
Catherine Bielajew
Keyword(s):  
Cognitive Impairment ◽  
Neuropsychological Tests ◽  
Clinical Utility ◽  
Cognitive Impairments ◽  
Neuropsychological Test ◽  
Test Battery ◽  
Neuropsychological Test Battery ◽  
Increased Risk ◽  
Chemo Fog ◽  
Risk Of Misclassification

Research on chemotherapy-induced cognitive impairment (the term ‘‘chemo-fog’’ is used by many investigators) supports the occurrence of subtle declines in function for a subset of recipients. Identification of vulnerable individuals via comprehensive neuropsychological batteries is complicated due to their lack of clinical utility and increased risk of misclassification. The goal of this paper was to evaluate the ability of a reduced battery to detect chemotherapy-related cognitive impairments. Data from our previous study (Ouimet et al. J Clin Exp Neuropsychol 31:73–89, 2009) were used to compare a comprehensive neuropsychological test battery comprising 23 tests with a reduced battery consisting of a subset of nine tests. A standardized regression-based approach revealed that a comparable numbers of participants were identified by both batteries, suggesting that individuals vulnerable to chemotherapy-induced cognitive impairment can be identified by a more selective battery. Further work is needed to clarify the neuropsychological tests most sensitive to detecting impairments associated with chemotherapy so that assessment batteries can be limited to these tests.

scholarly journals Investigation of a neuropsychological screen for chemo-fog

2011 ◽  
pp. 205-213
Author(s):  
Lea Ann Ouimet ◽  
Angela Stewart ◽  
Barbara Collins ◽  
Dwayne Schindler ◽  
Catherine Bielajew
Keyword(s):  
Cognitive Impairment ◽  
Neuropsychological Tests ◽  
Clinical Utility ◽  
Cognitive Impairments ◽  
Neuropsychological Test ◽  
Test Battery ◽  
Neuropsychological Test Battery ◽  
Increased Risk ◽  
Chemo Fog ◽  
Risk Of Misclassification

Research on chemotherapy-induced cognitive impairment (the term ‘‘chemo-fog’’ is used by many investigators) supports the occurrence of subtle declines in function for a subset of recipients. Identification of vulnerable individuals via comprehensive neuropsychological batteries is complicated due to their lack of clinical utility and increased risk of misclassification. The goal of this paper was to evaluate the ability of a reduced battery to detect chemotherapy-related cognitive impairments. Data from our previous study (Ouimet et al. J Clin Exp Neuropsychol 31:73–89, 2009) were used to compare a comprehensive neuropsychological test battery comprising 23 tests with a reduced battery consisting of a subset of nine tests. A standardized regression-based approach revealed that a comparable numbers of participants were identified by both batteries, suggesting that individuals vulnerable to chemotherapy-induced cognitive impairment can be identified by a more selective battery. Further work is needed to clarify the neuropsychological tests most sensitive to detecting impairments associated with chemotherapy so that assessment batteries can be limited to these tests.

P084 Feasibility study to examine underlying mechanisms for “Chemo Fog”

The Breast ◽  
2015 ◽  
Vol 24 ◽  
pp. S54
Author(s):  
V. Jenkins ◽  
H. Harder ◽  
M. Cercingani ◽  
H. Whiteley-Jones ◽  
R. Thwaites ◽  
...  
Keyword(s):  
Feasibility Study ◽  
Underlying Mechanisms ◽  
Chemo Fog
Sign in / Sign up

Export Citation Format

Share Document